... The IL-6 inhibitor drugs Actemra (tocilizumab) and Kevzara (sarilumab) work against RA, but have not been proven to help with PsA. In addition, Rituxan (rituximab) and Kineret (anakinra) can be helpful for RA that has not responded to other types of treatment. However, these drugs are not useful in treating PsA. Is It Possible To Have Both? ...
... The IL-6 inhibitor drugs Actemra (tocilizumab) and Kevzara (sarilumab) work against RA, but have not been proven to help with PsA. In addition, Rituxan (rituximab) and Kineret (anakinra) can be helpful for RA that has not responded to other types of treatment. However, these drugs are not useful in treating PsA. Is It Possible To Have Both? ...
... Kevzara (sarilumab), an IL-6 inhibitor, does not appear to be less effective in obese individuals with RA, nor does Kineret (anakinra), an IL-1 inhibitor.Should You Lose Weight If You Have RA? ...
... Kevzara (sarilumab), an IL-6 inhibitor, does not appear to be less effective in obese individuals with RA, nor does Kineret (anakinra), an IL-1 inhibitor.Should You Lose Weight If You Have RA? ...
... The following non-TNF biologic agents are FDA approved for RA: Abatacept (Orencia) Anakinra (Kineret) Rituximab (Rituxan) Sarilumab (Kevzara) Tocilizumab (Actembra) Biologics are given either subcutaneously or intravenously. ...
... The following non-TNF biologic agents are FDA approved for RA: Abatacept (Orencia) Anakinra (Kineret) Rituximab (Rituxan) Sarilumab (Kevzara) Tocilizumab (Actembra) Biologics are given either subcutaneously or intravenously. ...
... These anti-inflammatory drugs block proinflammatory cytokines, which are proteins in the immune system that attack healthy tissue in people with RA.Biologic drugs and other DMARDs that are used in the treatment of RA may protect against BMD loss, including: Enbrel (etanercept) Humira (adalimumab) Remicade (infliximab) Kineret (anakinra) Kevzara (sarilumab ...
... These anti-inflammatory drugs block proinflammatory cytokines, which are proteins in the immune system that attack healthy tissue in people with RA.Biologic drugs and other DMARDs that are used in the treatment of RA may protect against BMD loss, including: Enbrel (etanercept) Humira (adalimumab) Remicade (infliximab) Kineret (anakinra) Kevzara (sarilumab ...